About the Oncofertility Consortium
Women wish to have same reproductive preservation options that men now have, and the opportunity to know what the effect of treatment will be on future fertility. The solution to the problem of how to preserve a woman's fertility is within the reach of the biomedical community, but entails a very different approach and methodology for achieving success.
The next
steps require the involvement of the medical
community, the patients themselves and working
groups that involve multiple disciplines collaborating
in a new way. It will also require the National
Institutes of Health (NIH), academic
institutions and medical schools to recognize
the unique nature of a program that is multi-dimensional
and non-traditional.
To explore the reproductive future of patients facing life-preserving but fertility-threatening
cancer treatments, the Roadmap Interdisciplinary Oncofertility
Consortium brings together professionals in:
- Reproductive medicine
- Oncology
- Reproductive health research
- Biomechanics
- Materials science
- Mathematics
- Social science bioethics
- Religion
- Policy research
- Educational sciences
The Consortium is a framework to advance this new discipline of oncofertility and in the end can create new knowledge about the process of ovarian follicle development and provide the medical solution to fertility preservation for women with a fertility-altering cancer diagnosis.
The program's goals are to provide viable options to women with cancer and other fertility-threatening diseases, learn more about the nature and mechanisms of follicle development and better understand human relationships between health, disease and interventions that can protect the options for future fertility.
|
